Publications by authors named "Shreyaskumar Patel"

100Publications

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience.

Cancers (Basel) 2020 Oct 11;12(10). Epub 2020 Oct 11.

Department of Pediatrics, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers12102927DOI Listing
October 2020

Computational Drug Repositioning Identifies Potentially Active Therapies for Chordoma.

Neurosurgery 2020 Oct 5. Epub 2020 Oct 5.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyaa398DOI Listing
October 2020

Genomics, Morphoproteomics, and Treatment Patterns of Patients with Alveolar Soft Part Sarcoma and Response to Multiple Experimental Therapies.

Mol Cancer Ther 2020 05 3;19(5):1165-1172. Epub 2020 Mar 3.

Department of Investigational Cancer Therapeutics (Phase 1 Program), Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-19-0579DOI Listing
May 2020

Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study.

Diagnostics (Basel) 2020 Feb 25;10(3). Epub 2020 Feb 25.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/diagnostics10030125DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7151088PMC
February 2020

Positive Tumor Response to Combined Checkpoint Inhibitors in a Patient With Refractory Alveolar Soft Part Sarcoma: A Case Report.

J Glob Oncol 2018 09 6;4:1-6. Epub 2017 Jul 6.

Anthony P. Conley, Van Anh Trinh, Chrystia M. Zobniw, Kristi Posey, Wei-Lien Wang, Alexander J. Lazar, Neeta Somaiah, Jason Roszik, and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX; Jaime D. Martinez, Universidad Nacional Autonoma de Mexico; and Oscar G. Arrieta, Instituto Nacional de Cancerologia, Mexico City, Mexico.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JGO.2017.009993DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180844PMC
September 2018

The challenge of the management of adolescents and young adults with soft tissue sarcomas.

Pediatr Blood Cancer 2018 07 1;65(7):e27013. Epub 2018 Mar 1.

Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/pbc.27013
Publisher Site
http://dx.doi.org/10.1002/pbc.27013DOI Listing
July 2018

Primary Osteosarcoma in the Elderly Revisited: Current Concepts in Diagnosis and Treatment.

Curr Oncol Rep 2018 02 28;20(2):13. Epub 2018 Feb 28.

Victoria Radiology Associates, 2701 Hospital Drive, Victoria, TX, 77901, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-018-0658-1DOI Listing
February 2018

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.

J Immunother Cancer 2017 12 19;5(1):100. Epub 2017 Dec 19.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-017-0301-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735899PMC
December 2017

Early Evidence of Cardiotoxicity and Tumor Response in Patients with Sarcomas after High Cumulative Dose Doxorubicin Given as a Continuous Infusion.

Sarcoma 2017 26;2017:7495914. Epub 2017 Sep 26.

Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 450, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2017/7495914DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634608PMC
September 2017

The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.

Curr Oncol Rep 2017 Oct 13;19(12):78. Epub 2017 Oct 13.

Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Unit 455, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0641-2DOI Listing
October 2017

Progressive and Reversible Conduction Disease With Checkpoint Inhibitors.

Can J Cardiol 2017 10 8;33(10):1335.e13-1335.e15. Epub 2017 Jun 8.

Department of Cardiology, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cjca.2017.05.026DOI Listing
October 2017

Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes.

Clin Sarcoma Res 2017 15;7:11. Epub 2017 Jun 15.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-017-0077-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471883PMC
June 2017

Trabectedin and Eribulin: Where Do They Fit in the Management of Soft Tissue Sarcoma?

Curr Treat Options Oncol 2017 06;18(6):34

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd Unit 450, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-017-0477-xDOI Listing
June 2017

Clinical Decision Making: Integrating Advances in the Molecular Understanding of Spine Tumors.

Spine (Phila Pa 1976) 2016 Oct;41 Suppl 20:S171-S177

*Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD †Department of Neurological Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY ‡Oxford Spinal Unit, Oxford University Hospitals, Oxford, UK §Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX ¶Spine Service, Center for Orthopaedics and Traumatology (OUC), University Hospital Carl Gustav Carus at the TU Dresden, Dresden, Germany ||National Center for Spinal Disorders, Buda Health Center, School of PhD Studies, Semmelweis University, Budapest, Hungary **Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX ††Department of Neurosurgery, Rhode Island Hospital, The Warren Alpert Medical School of Brown University, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BRS.0000000000001836DOI Listing
October 2016

Benign Tumors of the Spine: Has New Chemotherapy and Interventional Radiology Changed the Treatment Paradigm?

Spine (Phila Pa 1976) 2016 Oct;41 Suppl 20:S178-S185

*Department of Orthopaedic, Centre Hospitalier Universitaire de Québec, Québec, QC, Canada †Department of Degenerative and Oncological Spine Surgery, Rizzoli Institute Bologna, Bologna, Italy ‡Division of Spine, Department of Orthopaedics, The University of British Columbia and Vancouver General Hospital, Vancouver, BC, Canada §Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX ¶Department of Orthopaedic Surgery, Kanazawa Medical University, Uchinada, Japan ||Department of Neurosurgery, The Ohio State University, Columbus, OH **Department of Neurosurgery, The John Hopkins University School of Medicine, Baltimore, MD ††Department of Neurosurgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/BRS.0000000000001818DOI Listing
October 2016

Emerging and established clinical, histopathological and molecular parametric prognostic factors for metastatic spine disease secondary to lung cancer: Helping surgeons make decisions.

J Clin Neurosci 2016 Dec 12;34:15-22. Epub 2016 Sep 12.

Division of Spine, Department of Orthopaedics, University of British Columbia and Vancouver Coastal Health, 6th Floor Blusson Spinal Cord Centre, Vancouver, British Columbia V5Z 1M9, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jocn.2016.05.023DOI Listing
December 2016

Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.

J Clin Oncol 2016 Oct;34(30):3680-3685

Vadim S. Koshkin, Cleveland Clinic, Cleveland, OH; Vanessa Bolejack, Cancer Research and Biostatistics, Seattle, WA; Lawrence H. Schwartz, Binsheng Zhao, Columbia University Medical Center, New York, NY; Richard L. Wahl, Mallinckrodt Institute of Radiology, Washington University in St Louis, St Louis, MO; Rashmi Chugh, Scott M. Schuetze, Laurence H. Baker, University of Michigan Medical School; Denise K. Reinke, Sarcoma Alliance for Research Through Collaboration, Ann Arbor, MI; Joo H. O, The Catholic University of Korea; Seoul St Mary's Hospital, Seoul, Republic of Korea; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.1858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065114PMC
October 2016

Can Abdominal Computed Tomography Imaging Help Accurately Identify a Dedifferentiated Component in a Well-Differentiated Liposarcoma?

J Comput Assist Tomogr 2016 Nov/Dec;40(6):872-879

From the *Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX; †University of Kentucky College of Medicine, Lexington, KY; ‡Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX; §Department of Radiology, University of Pennsylvania, Philadelphia, PA; and Departments of ∥Surgical Oncology, and ¶Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000462DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110394PMC
January 2017

Predictors of survival in patients with sarcoma admitted to the intensive care unit.

Clin Sarcoma Res 2016 19;6:12. Epub 2016 Jul 19.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd # 450, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13569-016-0051-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950117PMC
July 2016

Chemotherapy for soft tissue sarcoma.

Cancer 2016 10 19;122(19):2952-60. Epub 2016 Jul 19.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30191DOI Listing
October 2016

An Unusual Case of Central Retinal Vein Occlusion and Review of the Toxicity Profile of Regorafenib in GIST Patients.

Curr Oncol Rep 2016 08;18(8):49

Department of Sarcoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, unit 450, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-016-0536-7DOI Listing
August 2016

Chemotherapy for Bone Sarcoma in Adults.

J Oncol Pract 2016 Mar;12(3):208-16

The University of Texas MD Anderson Cancer Center, Houston, TX

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.009944DOI Listing
March 2016

Assessing the role of ¹⁸F-FDG PET and ¹⁸F-FDG PET/CT in the diagnosis of soft tissue musculoskeletal malignancies: a systematic review and meta-analysis.

Eur J Nucl Med Mol Imaging 2016 May 3;43(5):860-870. Epub 2015 Dec 3.

Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, 1400 Pressler, FCT 16.6005, Unit 1483, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048410PMC
http://dx.doi.org/10.1007/s00259-015-3242-zDOI Listing
May 2016

Cytotoxic and targeted therapy for treatment of pseudomyogenic hemangioendothelioma.

Clin Sarcoma Res 2015 19;5:22. Epub 2015 Oct 19.

Department of Sarcoma Medical Oncology, Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://www.clinicalsarcomaresearch.com/content/5/1/22
Publisher Site
http://dx.doi.org/10.1186/s13569-015-0037-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615364PMC
October 2015

Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial.

J Clin Oncol 2016 Mar 14;34(8):786-93. Epub 2015 Sep 14.

George D. Demetri, Dana-Farber Cancer Institute and Ludwig Center at Harvard, Boston, MA; Margaret von Mehren, Fox Chase Cancer Center; Arthur Staddon, University of Pennsylvania, Philadelphia; Hussein Tawbi, University of Pittsburgh Cancer Institute, Pittsburgh, PA; Robin L. Jones, Seattle Cancer Care Alliance, Seattle, WA; Martee L. Hensley, Memorial Sloan Kettering Cancer Center; Robert G. Maki, Mount Sinai Medical Center, New York, NY; Scott M. Schuetze, University of Michigan, Ann Arbor, MI; Mohammed Milhem, University of Iowa Hospitals and Clinics, Iowa City, IA; Anthony Elias, University of Colorado Cancer Center, Aurora, CO; Kristen Ganjoo, Stanford Hospital and Clinics, Stanford, CA; Brian A. Van Tine, Washington University in St Louis, St Louis, MO; Alexander Spira, Virginia Cancer Specialists, Fairfax, VA; Andrew Dean, St John of God Hospital-Bendat Cancer Centre, Subiaco, Western Australia, Australia; Nushmia Z. Khokhar, Youn Choi Park, Roland E. Knoblauch, and Trilok V. Parekh, Janssen Research & Development, Raritan, NJ; and Shreyaskumar R. Patel, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.62.4734
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.62.4734DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070559PMC
March 2016

Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?

Clin Orthop Relat Res 2015 Nov 22;473(11):3604-11. Epub 2015 Jul 22.

Department of Orthopaedic Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1448, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11999-015-4463-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586239PMC
November 2015

Chemotherapy for bone sarcomas in adults: the MD anderson experience.

Am Soc Clin Oncol Educ Book 2015 :e656-60

From the Department of Sarcoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2015.35.e656DOI Listing
February 2016

Chemotherapy for soft-tissue sarcomas.

Oncology (Williston Park) 2015 Jan;29(1):43-50

View Article

Download full-text PDF

Source
January 2015

Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.

Am J Clin Oncol 2017 Apr;40(2):189-193

Departments of *Lymphoma †Pathology ∥Urology ¶Sarcoma #Genitourinary Medical Oncology Divisions of ‡Cancer Medicine §Pharmacy, UT MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000128DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372498PMC
April 2017

Adult versus Pediatric Neuroblastoma: The M.D. Anderson Cancer Center Experience.

Sarcoma 2014 12;2014:375151. Epub 2014 Jun 12.

Department of Sarcoma Medical Oncology, M.D. Anderson Cancer Center, 1400 Holcombe Boulevard, Unit 463, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://downloads.hindawi.com/journals/sarcoma/2014/375151.pd
Web Search
http://www.hindawi.com/journals/sarcoma/2014/375151/
Publisher Site
http://dx.doi.org/10.1155/2014/375151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4082947PMC
July 2014

Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.

Eur J Endocrinol 2014 Sep 2;171(3):R111-22. Epub 2014 Jun 2.

Département de Médecine Nucléaire et de Cancérologie EndocrinienneRadiologie Interventionnelle, Chirurgie, Imagerie, Institut Gustave Roussy, Université Paris Sud, 114 Rue Edouard Vaillant 94805 villejuif Cedex, Paris, France andDepartment of Endocrine Neoplasia and Hormone DisordersUnit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-14-0113DOI Listing
September 2014

Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.

Am Soc Clin Oncol Educ Book 2014 :259-62

From the Sarcoma Center, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.14694/EdBook_AM.2014.34.259DOI Listing
November 2015

Pathologic and molecular features correlate with long-term outcome after adjuvant therapy of resected primary GI stromal tumor: the ACOSOG Z9001 trial.

J Clin Oncol 2014 May 17;32(15):1563-70. Epub 2014 Mar 17.

Christopher L. Corless, Violetta Kolesnikova, Charles D. Blanke, Michael C. Heinrich, Oregon Health and Science University, Portland, OR; Karla V. Ballman, Mayo Clinic, Rochester, MN; Cristina R. Antonescu and Ronald P. DeMatteo, Memorial Sloan-Kettering Cancer Center; Robert G. Maki, Mt Sinai School of Medicine, New York, NY; Peter W.T. Pisters and Shreyaskumar Patel, University of Texas MD Anderson Cancer Center, Houston, TX; Martin E. Blackstein, Mount Sinai Hospital, Toronto, Ontario, Canada; George D. Demetri, Dana-Farber Cancer Institute, Boston, MA; Margaret von Mehren, Fox Chase Cancer Institute, Philadelphia, PA; Martin D. McCarter, University of Colorado School of Medicine, Aurora, CO; and Kouros Owzar, Duke University School of Medicine, Durham, NC.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2013.51.2046
Publisher Site
http://dx.doi.org/10.1200/JCO.2013.51.2046DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4026579PMC
May 2014

Management and outcome of 239 adolescent and adult rhabdomyosarcoma patients.

Cancer Med 2013 Aug 15;2(4):553-63. Epub 2013 Jul 15.

Hematology Oncology Department Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida ; Department of Sarcoma Medical Oncology MD Anderson Cancer Center, University of Texas Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.92DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799290PMC
August 2013

Vascular sarcomas.

Curr Oncol Rep 2013 Aug;15(4):347-55

Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 450, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s11912-013-0328-2
Publisher Site
http://dx.doi.org/10.1007/s11912-013-0328-2DOI Listing
August 2013

The role of chemotherapy in advanced solitary fibrous tumors: a retrospective analysis.

Clin Sarcoma Res 2013 May 11;3(1). Epub 2013 May 11.

Department of Sarcoma Medical Oncology Unit 0450, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2045-3329-3-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660184PMC
May 2013

The treatment outcome for adult patients with Ewing's sarcoma.

Curr Oncol Rep 2013 Aug;15(4):372-7

Department of Medicine, Division of Oncology, Stanford Comprehensive Cancer Center, 875 Blake Wilbur Drive, Stanford, CA 94305, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0317-5DOI Listing
August 2013

Exploring novel therapeutic targets in GIST: focus on the PI3K/Akt/mTOR pathway.

Curr Oncol Rep 2013 Aug;15(4):386-95

The University of Texas M.D. Anderson Cancer Center, 1400 Holcombe Blvd, Unit 450, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-013-0316-6DOI Listing
August 2013

A 62-year-old woman with osteogenic sarcoma in the contralateral breast 15 years after treatment for breast cancer.

Semin Oncol 2013 Apr;40(2):135-44

Department of Radiation Oncology, Regional Cancer Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.01.010DOI Listing
April 2013

Long-term efficacy of imatinib for treatment of metastatic GIST.

Cancer Chemother Pharmacol 2013 Aug 17;72(2):277-86. Epub 2013 Mar 17.

Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2135-8DOI Listing
August 2013

Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.

Clin Genitourin Cancer 2012 Sep 13;10(3):210-2. Epub 2012 Apr 13.

University of Texas M.D. Anderson Cancer Center, Genitourinary Medical Oncology, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2012.03.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4121061PMC
September 2012

Adjuvant chemotherapy for soft tissue sarcomas.

Surg Oncol Clin N Am 2012 Apr 23;21(2):243-53. Epub 2012 Jan 23.

Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2011.12.006DOI Listing
April 2012

Managing progressive disease in patients with GIST: factors to consider besides acquired secondary tyrosine kinase inhibitor resistance.

Cancer Treat Rev 2012 Aug 27;38(5):467-72. Epub 2011 Oct 27.

Department of Sarcoma Medical Oncology, The University of Texas, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2011.10.001DOI Listing
August 2012

Soft tissue sarcomas of the popliteal fossa: a single-institution retrospective review.

Cancer 2011 Jun 29;117(12):2728-34. Epub 2010 Dec 29.

Division of Pediatrics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.25736DOI Listing
June 2011

Liposarcoma in children and young adults: a multi-institutional experience.

Pediatr Blood Cancer 2011 Dec 10;57(7):1142-6. Epub 2011 Mar 10.

Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.23095DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3134599PMC
December 2011

Current and emerging pharmacological treatments for gastrointestinal stromal tumour.

Drugs 2011 Feb;71(3):321-30

Department of Medicine, Division of Oncology, Stanford Comprehensive Cancer Center, Stanford, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11585370-000000000-00000DOI Listing
February 2011

Navigating risk stratification systems for the management of patients with GIST.

Ann Surg Oncol 2011 Jun 7;18(6):1698-704. Epub 2011 Jan 7.

Department of Sarcoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-010-1496-zDOI Listing
June 2011

Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators.

J Clin Endocrinol Metab 2011 Mar 29;96(3):717-25. Epub 2010 Dec 29.

Department of Endocrine Neoplasia and Hormonal Disorders, Unit 1461, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/jc.2010-1946DOI Listing
March 2011

Gastrointestinal Stromal Tumors (GIST) special issue. Preface.

Cancer Chemother Pharmacol 2011 Jan 30;67 Suppl 1:S1. Epub 2010 Nov 30.

Department of Sarcoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1511-xDOI Listing
January 2011